• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据基因表达谱进行亚组分类,提高儿童 B 前体细胞急性淋巴细胞白血病的复发风险预测。

Subgrouping by gene expression profiles to improve relapse risk prediction in paediatric B-precursor acute lymphoblastic leukaemia.

机构信息

School of Mathematics and Statistics, Hanshan Normal University, Chaozhou, China.

Institute of Paediatrics, Guangzhou Women and Children's Medical Centre, Guangzhou Medical University, Guangzhou, China.

出版信息

Cancer Med. 2021 Jun;10(11):3782-3793. doi: 10.1002/cam4.3842. Epub 2021 May 13.

DOI:10.1002/cam4.3842
PMID:33987975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8178509/
Abstract

Relapsed acute lymphoblastic leukaemia (ALL) remains a prevalent paediatric cancer and one of the most common causes of mortality from malignancy in children. Tailoring the intensity of therapy according to early stratification is a promising strategy but remains a major challenge due to heterogeneity and subtyping difficulty. In this study, we subgroup B-precursor ALL patients by gene expression profiles, using non-negative matrix factorization and minimum description length which unsupervisedly determines the number of subgroups. Within each of the four subgroups, logistic and Cox regression with elastic net regularization are used to build models predicting minimal residual disease (MRD) and relapse-free survival (RFS) respectively. Measured by area under the receiver operating characteristic curve (AUC), subgrouping improves prediction of MRD in one subgroup which mostly overlaps with subtype TCF3-PBX1 (AUC = 0·986 in the training set and 1·0 in the test set), compared to a global model published previously. The models predicting RFS displayed acceptable concordance in training set and discriminate high-relapse-risk patients in three subgroups of the test set (Wilcoxon test p = 0·048, 0·036, and 0·016). Genes playing roles in the models are specific to different subgroups. The improvement of subgrouped MRD prediction and the differences of genes in prediction models of subgroups suggest that the heterogeneity of B-precursor ALL can be handled by subgrouping according to gene expression profiles to improve the prediction accuracy.

摘要

复发急性淋巴细胞白血病(ALL)仍然是一种常见的儿科癌症,也是儿童恶性肿瘤死亡的最常见原因之一。根据早期分层来调整治疗强度是一种很有前途的策略,但由于异质性和亚型划分困难,这仍然是一个主要挑战。在这项研究中,我们通过基因表达谱将 B 前体 ALL 患者进行亚组分类,使用非负矩阵分解和最小描述长度来无监督地确定亚组数量。在四个亚组中的每一个亚组中,使用逻辑回归和 Cox 回归与弹性网络正则化来建立预测微小残留病(MRD)和无复发生存(RFS)的模型。通过接收者操作特征曲线下的面积(AUC)来衡量,与之前发表的全球模型相比,亚组分类在一个主要与 TCF3-PBX1 亚型重叠的亚组中提高了 MRD 预测的准确性(在训练集中 AUC 为 0.986,在测试集中 AUC 为 1.0)。在训练集中,预测 RFS 的模型显示出可接受的一致性,并在测试集中的三个亚组中区分出高复发风险患者(Wilcoxon 检验 p=0.048、0.036 和 0.016)。在模型中起作用的基因特定于不同的亚组。MRD 预测的亚组化改善和亚组预测模型中基因的差异表明,根据基因表达谱进行亚组分类可以处理 B 前体 ALL 的异质性,从而提高预测准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8533/8178509/ab223ede2942/CAM4-10-3782-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8533/8178509/4b644b228dbe/CAM4-10-3782-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8533/8178509/d592d559ebea/CAM4-10-3782-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8533/8178509/16d283594f42/CAM4-10-3782-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8533/8178509/345acc525771/CAM4-10-3782-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8533/8178509/ab223ede2942/CAM4-10-3782-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8533/8178509/4b644b228dbe/CAM4-10-3782-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8533/8178509/d592d559ebea/CAM4-10-3782-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8533/8178509/16d283594f42/CAM4-10-3782-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8533/8178509/345acc525771/CAM4-10-3782-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8533/8178509/ab223ede2942/CAM4-10-3782-g003.jpg

相似文献

1
Subgrouping by gene expression profiles to improve relapse risk prediction in paediatric B-precursor acute lymphoblastic leukaemia.根据基因表达谱进行亚组分类,提高儿童 B 前体细胞急性淋巴细胞白血病的复发风险预测。
Cancer Med. 2021 Jun;10(11):3782-3793. doi: 10.1002/cam4.3842. Epub 2021 May 13.
2
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.一个包含微缺失的风险评分可改善对儿童标准风险和中等风险前体B细胞急性淋巴细胞白血病复发的预测。
Br J Haematol. 2018 Feb;180(4):550-562. doi: 10.1111/bjh.15056. Epub 2017 Nov 30.
3
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending relapse: results of the ALL-BFM-SCT 2003 trial.异基因造血干细胞移植后复发儿童急性淋巴细胞白血病微小残留病监测可识别即将复发:ALL-BFM-SCT 2003 试验结果。
J Clin Oncol. 2015 Apr 10;33(11):1275-84. doi: 10.1200/JCO.2014.58.4631. Epub 2015 Jan 20.
4
Effective Response Metric: a novel tool to predict relapse in childhood acute lymphoblastic leukaemia using time-series gene expression profiling.有效反应度量:使用时间序列基因表达谱预测儿童急性淋巴细胞白血病复发的新工具。
Br J Haematol. 2018 Jun;181(5):653-663. doi: 10.1111/bjh.15252.
5
Low expression of and predicts risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a retrospective cohort study.低表达 和 预测儿童 B 细胞前体急性淋巴细胞白血病复发风险:一项回顾性队列研究。
Pediatr Hematol Oncol. 2020 Nov;37(8):732-746. doi: 10.1080/08880018.2020.1798572. Epub 2020 Aug 17.
6
Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.基因表达分类器用于无复发生存和微小残留病可改善儿童 B 前体细胞急性淋巴细胞白血病的风险分类和预后预测。
Blood. 2010 Feb 18;115(7):1394-405. doi: 10.1182/blood-2009-05-218560. Epub 2009 Oct 30.
7
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96.诱导缓解后微小残留病是中危复发急性淋巴细胞白血病预后的最强预测因素——ALL-REZ BFM P95/96 试验的长期结果。
Eur J Cancer. 2013 Apr;49(6):1346-55. doi: 10.1016/j.ejca.2012.11.010. Epub 2012 Dec 19.
8
Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia.儿童急性髓系白血病与急性淋巴细胞白血病中通过WT1定量监测微小残留病(MRD)的比较。
Eur Rev Med Pharmacol Sci. 2015;19(14):2679-88.
9
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.儿童和年轻成人低危急性淋巴细胞白血病微小残留病灶定义下的治疗减少(UKALL 2003):一项随机对照试验。
Lancet Oncol. 2013 Mar;14(3):199-209. doi: 10.1016/S1470-2045(12)70600-9. Epub 2013 Feb 7.
10
Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.硼替佐米再诱导化疗治疗首次复发的高危 ALL:来自儿童肿瘤协作组的报告。
Br J Haematol. 2019 Jul;186(2):274-285. doi: 10.1111/bjh.15919. Epub 2019 Apr 7.

本文引用的文献

1
SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness.SOCS2 是 AML 中具有高度预后价值的 4 基因特征的一部分,并促进疾病侵袭性。
Sci Rep. 2019 Jun 24;9(1):9139. doi: 10.1038/s41598-019-45579-0.
2
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia.NG2 抗原是 MLL 重排型 B 细胞急性淋巴细胞白血病的治疗靶点。
Leukemia. 2019 Jul;33(7):1557-1569. doi: 10.1038/s41375-018-0353-0. Epub 2019 Jan 11.
3
Single cell analysis of clonal architecture in acute myeloid leukaemia.
急性髓系白血病克隆结构的单细胞分析。
Leukemia. 2019 May;33(5):1113-1123. doi: 10.1038/s41375-018-0319-2. Epub 2018 Dec 19.
4
Annexin A1 expression is correlated with malignant potential of renal cell carcinoma.膜联蛋白A1的表达与肾细胞癌的恶性潜能相关。
Int J Urol. 2019 Feb;26(2):284-290. doi: 10.1111/iju.13869. Epub 2018 Dec 2.
5
Ceramide kinase regulates the migration of bone marrow-derived mesenchymal stem cells.神经酰胺激酶调节骨髓间充质干细胞的迁移。
Biochem Biophys Res Commun. 2019 Jan 8;508(2):361-367. doi: 10.1016/j.bbrc.2018.11.154. Epub 2018 Nov 28.
6
Structural insights into DNA degradation by human mitochondrial nuclease MGME1.人类线粒体核酸酶 MGME1 降解 DNA 的结构研究
Nucleic Acids Res. 2018 Nov 16;46(20):11075-11088. doi: 10.1093/nar/gky855.
7
Annexin A1 regulates EGFR activity and alters EGFR-containing tumour-derived exosomes in head and neck cancers.膜联蛋白 A1 调节表皮生长因子受体活性并改变头颈部癌症中含有表皮生长因子受体的肿瘤衍生外泌体。
Eur J Cancer. 2018 Oct;102:52-68. doi: 10.1016/j.ejca.2018.07.123. Epub 2018 Aug 21.
8
A causal mechanism for childhood acute lymphoblastic leukaemia.儿童急性淋巴细胞白血病的因果机制。
Nat Rev Cancer. 2018 Aug;18(8):471-484. doi: 10.1038/s41568-018-0015-6.
9
Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia.自动化数据库引导的专家监督导向,用于急性白血病的免疫表型诊断和分类。
Leukemia. 2018 Apr;32(4):874-881. doi: 10.1038/leu.2017.313. Epub 2017 Nov 1.
10
End of therapy minimal residual disease (MRD) measurement in children with ALL does not predict relapse.急性淋巴细胞白血病患儿治疗结束时的微小残留病(MRD)检测不能预测复发。
Hematol Oncol Stem Cell Ther. 2018 Mar;11(1):41-43. doi: 10.1016/j.hemonc.2017.05.033. Epub 2017 Jun 17.